We are looking for a PhD candidate who will contribute to the development of non-invasive biomarkers for the prediction of outcome esophagogastric cancer treatment.Esophagogastric cancer has a notoriously poor prognosis, although recent developments in the field of systemic therapy, including immunotherapy, have significantly improved survival outcomes. However, these therapies may come with side effects. Thus, being able to select the right patient for the right drug remains the pinnacle of medical oncological research efforts.
Non-invasive assessment of metabolism directly in the tumor sites of interest using Magnetic Resonance Imaging (MRI) may provide such biomarkers to predict treatment outcome. Alternatively, from analyses of circulating tumor DNA (ctDNA), peripheral blood monocytes (PBMCs) or the faecal microbiome biomarkers may be derived to predict treatment outcome.
Therefore, in this PhD-trajectory, the candidate will set-up and coordinate a multi-center study to investigate whether MRI scans measuring tumor metabolism can predict outcome of first-line treatment of esophagogastric cancer. In addition, the PhD candidate will be involved in the analyses of ctDNA, PBMCs and faecal microbiome of currently accruing clinical studies (among others the LyRICX study (see clinicaltrials.gov NCT03764553).
Our group has expertise in non-invasive biomarker development and works closely together with experts in the field of MRI, ctDNA. PBMCs and the faecal microbiome within Cancer Center Amsterdam, which will allow for the perfect environment to bring this project to a successful end.
Your main task will be to set-up and coordinate the multi-center metabolic MRI study.
- You will work on the entire MRI chain. You will operate state-of-the-art MRI machines (7 Tesla), acquire MRI data, and analyse the MRI data.
- You will closely collaborate with the MRI-physics group at the Amsterdam UMC, in which you will closely work together with other PhD candidates (with technical and medical backgrounds).
- You will perform research on biomarkers such as ctDNA, PBMCs and microbiome.
- Your will be publish in top-rated high-impact peer-reviewed journals.
- You will regularly be presenting the work at (international) conferences.
- You will assist in relevant teaching activities.
- You will collaborate with your fellow PhD students.